TNFSF10 and neoplasm: These considerations suggest that by binding to MUC16, Meso64-TR3 may also saturate and reduce or even eliminate the available binding sites on the biomarker for adhesive interactions with mesothelin-expressing normal endothelium, thereby limiting the dissemination of tumor cells in addition to augmenting TRAIL-mediated target cell death [55].